MEL lowered total bilirubin, ALT, AST, TNF-α, and IL-1β levels in acute liver failure mice, improving survival rates, reducing symptoms, and relieving hepatic inflammation. MEL demonstrated antioxidant and anti-inflammatory properties in LPS-stimulated RAW264.7 macrophages. The gene discussed is IL1B; the disease is acute liver failure.